scispace - formally typeset
J

Joseph S. Bresee

Researcher at Centers for Disease Control and Prevention

Publications -  261
Citations -  35039

Joseph S. Bresee is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Rotavirus & Vaccination. The author has an hindex of 78, co-authored 255 publications receiving 32225 citations. Previous affiliations of Joseph S. Bresee include National Center for Immunization and Respiratory Diseases.

Papers
More filters
Journal ArticleDOI

Epidemic infectious gastrointestinal illness aboard U.S. Navy ships deployed to the Middle East during peacetime operations – 2000–2001

TL;DR: A retrospective analysis of weekly reported disease and non-battle injury health data collected from 44 U.S. Navy ships while sailing in the 5th Fleet in 2000 – 2001 found explosive outbreaks due to viruses and bacteria with the potential of incapacitating large proportions of the crew raise serious concerns of mission impact and military readiness.
Journal ArticleDOI

Global Seasonal Influenza Mortality Estimates: A Comparison of 3 Different Approaches.

TL;DR: Comparison analysis of three influenza mortality projects from the United States, the Netherlands, and the Institute for Health Metrics and Evaluation found that influenza-associated respiratory death counts were comparable between CDC and GLaMOR; IHME estimate was considerably lower.
Journal Article

[Epidemiological study of rotavirus diarrhea in Beijing, China - a hospital-based surveillance from 1998 - 2001].

TL;DR: Rotavirus diarrhea was an important infectious disease among children in Beijing and safe and effective rotavirus vaccines for the prevention of severe diarrheas and the reduction of treatment costs are of significant importance to China.
Journal ArticleDOI

Implementing rotavirus vaccination in Asia.

TL;DR: The conference participants agreed that decisions on the introduction of rotavirus vaccines may require additional disease burden data in some countries and that economic evaluations will help policymakers reach decisions on nationwide rotav virus vaccine implementation.